Roth MKM transferred coverage of American Vanguard to who raised the firm’s price target to $13 from $12 and keeps a Buy rating on the shares. The company looks well-positioned as a unique niche player in agriculture inputs, with additional upside for faster growth through the development of precision agriculture equipment and low-toxicity biologic crop inputs, the analyst tells investors in a research note. Normalizing channel inventories and internal operational cost initiatives should also drive American Vanguard’s growth and margins, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>